GSK Consumer Nigeria Plc in a bid to transfer the manufacture of some of its products to a local partner has chosen Fidson Healthcare Plc as its manufacturing partner.
In a statement made available on the website of the Nigerian Stock Exchange (NSE), the company announced it had picked Fidson Healthcare Plc as its preferred local contract manufacturing partner.
GSK will thus transition the manufacture of its respiratory and wellness products to Fidson from the third quarter of 2021. The firm, however, maintained that activities would continue at its Agbara plant till then.